PharmEasy might need to sell Thyrocare
The diagnostics firm was acquired at great cost, but is unable to support PharmEasy’s core online pharmacy business.
Why read this story?
Editor's note: Just a few months ago, it looked like PharmEasy was well on the way to listing on the public markets at a valuation of over $5 billion. But with investors fast losing their appetite for technology stocks in recent months, the online drugs and medical services startup shelved its IPO in November. Now, some of the decisions it took in the run-up to the withdrawn public offer are beginning to bite. In particular, its acquisition of diagnostics chain Thyrocare in June 2021, which has become a millstone around its neck, threatening to thwart PharmEasy’s ambition to build India’s biggest pharmacy. Nothing could be more ironic. Currently, Thyrocare is the best business in PharmEasy’s portfolio, which includes retail and B2B sales of pharmaceuticals, doctor consultations and diagnostic services. Only Thyrocare makes a profit; in 2020-21, it clocked Rs 152 crore. In the same year, API Holdings, PharmEasy’s parent, recorded operational losses of Rs 3,992 crore and posted a net loss of Rs 2,731 crore. PharmEasy acquired Thyrocare almost a year and a half after the COVID-19 pandemic struck, hoping that the …
More in Internet
You may also like
Eternal’s leap of faith: exit Goyal, enter Dhindsa
Deepinder Goyal’s handing of Eternal’s reins to Albinder Dhindsa raises uncomfortable questions about timing, risk and whether shareholders are being asked to trust yet another reassuring narrative.
BellaVita’s success has opened the floodgates to cheap fragrance brands
In less than five years, BellaVita has become one of the biggest fragrance brands in India. This has given several others confidence to follow the same playbook and sell cheap perfumes disguised as luxury.
Eternal, Swiggy, Zepto are all unskilled worker arbitrage businesses
Exploitation of unskilled workers is at the heart of quick-delivery service businesses in India. They should be valued for what they are and not what they pretend to be, a trait that has taken a devious form of wanting it both ways.